Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial www.sciencedirect.com/science/arti... #hvhebron #onco

A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma aacrjournals.org/clincancerre... #hvhebron #onco [Text complet]

EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]

#ONCO CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

https://www.stocktitan.net/news/ONCO/corrected-onconetix-provides-strategic-bridge-financing-to-realbotix-ugbxf15a30pt.html?utm_source=stocktitan-bluesky&utm_medium=social

#ONCO Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

https://www.stocktitan.net/news/ONCO/onconetix-provides-strategic-bridge-financing-to-realbotix-llc-in-0m6mgborwhpa.html?utm_source=stocktitan-bluesky&utm_medium=social

Overall survival and long-term outcomes from the randomized, double-blind, placebo-controlled, phase III IMerge trial of imetelstat for lower-risk myelodysplastic syndromes. haematologica.org/article/view... #hvhebron #onco [Text complet]

Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort. link.springer.com/article/10.1... #hvhebron #onco [Text complet]

Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success. www.esmoopen.com/article/S205... #hvhebron #onco [Text complet]

Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: a multicenter study in Southern Europe. academic.oup.com/oncolo/advan... #hvhebron #onco [Text complet]

Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors. jitc.bmj.com/content/14/9... #hvhebron #onco [Text complet]

Pharmacokinetics and safety of pembrolizumab administered subcutaneously or intravenously with platinum doublet chemotherapy for first-line treatment of metastatic non-small cell lung cancer: The phase 3 KEYNOTE-A86 study www.jtocrr.org/article/S266... #hvhebron #onco [Text complet]

Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT www.international-journal-of-gynecological-cancer.com/article/S104... #hvhebron #onco [Text complet]

Relative Mutant Allele Frequency Role in ctDNA-Guided Anti-Epidermal Growth Factor Receptor Rechallenge in Metastatic Colorectal Cancer. ascopubs.org/doi/10.1200/... #hvhebron #onco [Text complet]

#ONCO Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events

https://www.stocktitan.net/news/ONCO/onconetix-acquisition-target-realbotix-launches-pilot-with-leading-zj3l3cfqh7ha.html